Note 12 - Commitments and Contingencies (Details) (USD $)			1 Months Ended			1 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Jul. 31, 2014 Td Vaccine [Member]	Oct. 17, 2012 Td Vaccine [Member]	Sep. 30, 2014 Supply Agreement with Hospira [Member]	Dec. 22, 2011 H Lundbeck AS [Member]	Sep. 30, 2014 H Lundbeck AS [Member]	Jan. 02, 2014 Betimol Acquisition [Member]	Sep. 30, 2014 Betimol Acquisition [Member]
Note 12 - Commitments and Contingencies (Details) [Line Items]
Number of NDA's off Patent Branded Injectable Products							3
Payments to Acquire Businesses, Gross						$ 45,000,000		$ 7,500,000	$ 7,500,000
Business Combination, Additional Consideration Owed						15,000,000			4,600,000
Commitments and Contingencies	20,728,000	14,728,000					15,000,000
Business Acquisition, Consideration, Sales Multiplier								1.5
Business Combination, Contingent Consideration, Liability									4,600,000
Long-term Purchase Commitment, Period				2 years
Distribution Agreement Contract Term			1 year
Purchase Obligation, Future Minimum Payments, Remainder of Fiscal Year			2,500,000		2,100,000
Purchase Obligation, Due in Second Year			$ 4,800,000		$ 2,100,000
Number of Products Related to Minimum Annual Purchase Obligations					2